Founded in 2013, Medikure Pharmaceuticals is a globally recognized leader in the export of Pharmaceuticals, Nutraceuticals, Herbal Medicines, Medical Devices, and Personal Care Products.
With a strong foundation built on deep expertise and strategic global partnerships, we deliver healthcare excellence across major international markets—including Asia, the Middle East, Africa, North America, and Latin America. Our operations are anchored in trust, quality, and a thorough understanding of international regulatory standards.
Leveraging an extensive contract manufacturing network across India and abroad, we offer compliant, and cost-effective healthcare solutions tailored to diverse market needs.
We are currently exporting to over 25 countries, with a steadfast commitment to innovation, integrity, and global health advancement.
We offer a comprehensive and evolving portfolio of healthcare products under the following categories
Delivering high quality, compliant healthcare products to global markets with efficiency, integrity and reliability that improve quality of life and promote long-term wellness for people around the world.
To be a trusted organization in global healthcare distribution, ensuing accessibility, compliance, and sustainable healthcare solutions worldwide.
Product Sourcing - A comprehensive portfolio across Pharmaceuticals, Nutraceuticals, Oncology (Anti-Cancer), and Medical Devices sourced through trusted global networks and compliant manufacturers.
Time & Cost Management - Cost-effective procurement and timely fulfilment of orders through optimized supply chain strategies and agile vendor coordination.
Regulatory Services - A highly qualified regulatory team delivers dossiers in CTD and ACTD formats, with expertise in country-specific registration requirements across Asia, Africa, and LATAM.
Contract Manufacturing & Private Label - End-to-end solutions for custom formulations, packaging, and branding.
Export Compliance & Documentation - Robust support for export documentation, customs clearance, and regulatory filings, ensuring smooth cross-border transactions.
13
25